Agilent Technologies specializes in providing application-focused solutions within the life sciences, diagnostics, and applied chemical markets globally. The company operates through three main segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers a variety of analytical instruments, including chromatography systems and mass spectrometry equipment, alongside laboratory automation and analytical software. The Diagnostics and Genomics segment focuses on advanced genetic analysis tools, including DNA mutation detection and gene expression profiling, as well as quality control solutions for nucleic acid samples. The Agilent CrossLab segment supplies laboratory consumables, custom chemistries, and a range of support services aimed at optimizing laboratory operations. With a strong customer base across biopharmaceutical, environmental, academic, and government sectors, Agilent Technologies emphasizes collaboration and innovation to address evolving scientific needs. Headquartered in Santa Clara, California, the company utilizes multiple sales channels, including direct sales and electronic commerce, to reach its diverse clientele.
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on advancing the understanding of genome sequence and structure in relation to human health, disease, and species evolution. The company develops innovative genomic solutions, including the Arima-HiC proximity ligation kit, which captures the three-dimensional organization of chromatin. This method allows for the identification of long-range genomic interactions, even when sequences are distally located in linear arrangements. Additionally, Arima offers the Arima-HiChIP protocol, which combines Hi-C techniques with chromatin immunoprecipitation to enrich for protein-mediated interactions. These tools facilitate various genomic applications, such as studying gene regulation through promoter-enhancer interactions and constructing genome assemblies. Incorporated in 2015, Arima Genomics aims to support scientific research by providing critical insights into genetic structures and their implications for health and disease.
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.
Arima Genomics, Inc. is a biotechnology company based in San Diego, California, focused on advancing the understanding of genome sequence and structure in relation to human health, disease, and species evolution. The company develops innovative genomic solutions, including the Arima-HiC proximity ligation kit, which captures the three-dimensional organization of chromatin. This method allows for the identification of long-range genomic interactions, even when sequences are distally located in linear arrangements. Additionally, Arima offers the Arima-HiChIP protocol, which combines Hi-C techniques with chromatin immunoprecipitation to enrich for protein-mediated interactions. These tools facilitate various genomic applications, such as studying gene regulation through promoter-enhancer interactions and constructing genome assemblies. Incorporated in 2015, Arima Genomics aims to support scientific research by providing critical insights into genetic structures and their implications for health and disease.
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.
Genohm SA is a developer of cloud-based software solutions focused on laboratory management, founded in 2002 and headquartered in Lausanne, Switzerland. The company specializes in software automation solutions that integrate Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), and order management. Genohm's SLims platform is designed to allow scientists to customize their digital data management systems according to individual laboratory workflows. The company's client base includes a diverse range of international organizations, such as biobanks, research and development laboratories, next-generation sequencing laboratories in universities and hospitals, and biotechnology companies. Since May 2018, Genohm has operated as a subsidiary of Agilent Technologies, Inc.
LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Multiplicom N.V., founded in 2010 and based in Niel, Belgium, specializes in developing molecular diagnostic test kits that facilitate the collection of genetic information for personalized treatment. The company offers a range of diagnostic assays across three main segments: human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiovascular disorders, such as various BRCA and HNPCC assays. In oncology, Multiplicom provides kits for molecular tumor pathology and cancer genetics, including several BRCA and somatic tests. For prenatal diagnostics, the company offers the Clarigo product to detect chromosome abnormalities. Multiplicom also operates an informatics facility in Gent, Belgium, and has an additional office in Lyon, France. As of January 2017, Multiplicom N.V. is a subsidiary of Agilent Technologies, Inc.
Molecular Assemblies, Inc. is a San Diego-based company that specializes in enzymatic DNA synthesis technology, which allows for the precise reading and writing of DNA. Founded in 2013, the company targets multiple markets, including life sciences, industrial applications, information storage, nanotechnology, and DNA electronics. Its innovative approach is inspired by natural processes and focuses on producing long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner. The company boasts a strong executive and scientific team and holds an extensive intellectual property portfolio. It has garnered investments from various notable entities, highlighting its potential to advance products in industrial synthetic biology, personalized therapeutics, and precision diagnostics.
LaserGen, Inc. is a biotechnology company based in Houston, Texas, founded in 2002. It specializes in developing and commercializing nucleotides and tools that cater to life science solutions, particularly in the fields of next-generation sequencing and histology. The company creates technologies designed to detect heritable and somatic sequence variations in the human genome, which serve as diagnostic tools for disease management. By focusing on innovative chemistry, LaserGen aims to provide scientists with cost-effective and accurate platforms for DNA sequencing and other genomics applications. As of May 2018, LaserGen operates as a subsidiary of Agilent Technologies, Inc.
Cartagenia specializes in providing software and services for clinical genetics and molecular pathology laboratories. The company offers a platform designed for the assessment and reporting of clinical genomics data derived from next-generation sequencing and microarrays. This platform facilitates the visualization, assessment, and reporting of genetic data in relation to patient information, enabling genetic labs and clinicians to conduct clinically relevant analyses efficiently. By improving the speed and quality of genetic interpretation and counseling, Cartagenia aims to enhance the overall experience for patients and caregivers.
Gen9 is a privately held company based in Cambridge, Massachusetts, that specializes in next-generation gene synthesis technology. Founded in 2009 by leaders in synthetic biology, Gen9 focuses on automating the high-throughput production of DNA constructs, which enhances the efficiency, cost-effectiveness, and accuracy of DNA synthesis compared to traditional methods. The company aims to leverage its innovative technology to facilitate applications in various industries, including pharmaceuticals, biofuels, and enzyme production. By advancing synthetic biology, Gen9 strives to expand the global capacity for DNA content production, supporting a range of constructive applications.
Stratagene Corporation develops, manufactures, and markets life science research products in the United States and internationally. The company supports advances in science by inventing, manufacturing, and distributing products that simplify, accelerate, and improve research. Its products are used in the academic, industrial, and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery, and toxicology.
SynPro
Acquisition in 2006
SynPro Corp. manufactures short synthetic DNA and RNA molecules for the pharmaceutical and biotech industries. Its products are used as components of drugs in clinical trials. It makes synthetic nucleic acids used in biotech research.
Computational Biology
Acquisition in 2005
Computational Biology Corp. develops microarray-based techniques for understanding gene regulation in disease. The company utilizes ChIP-on-chip technology, which uses chromatin immuno-precipitation (ChIP) to discover how regulatory proteins interact with the genome of living cells.
Silicon Genetics provides data analysis and management solutions focusing on molecular biology, statistics, and IT. The company’s products include GeneSpring, a visualization and analysis solution for genomic expression data on the desktop; Varia, which is genetic analysis software for life science researchers; and GeNet, provides scalable repository for expression data.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.